Page 3 of Pfizer

Pfizer COVID pill showed no benefit in younger adults, says Study

The results from a 109,000-patient Israeli study are likely to renew questions about the U.S. government’s use of Paxlovid, which…

August 25, 2022 08:54 IST

Pfizer seeks OK of updated COVID-19 vaccine booster for fall

The Food and Drug Administration on Monday ordered vaccine makers to tweak their shots to target BA.4 and BA.5 that…

Updated: August 23, 2022 08:41 IST

GSK, Sanofi, Haleon, Pfizer, health news, pharma news, shares, share market,

After Zantac litigation dip, shares of drugmakers stabilise

Zantac, originally marketed by a forerunner of GSK, has been sold by several companies since the loss of patent exclusivity…

August 12, 2022 18:21 IST

Pfizer, Pfizer India, patient assistance, health news, healthcare news,

S Sridhar resigns as MD of Pfizer; To take early retirement

He will continue to serve in his current position until the identification, selection and transition to the new leadership takes…

August 10, 2022 18:34 IST

Myovant, Pfizer, endometriosis, pain management, menstrual pains, health news, pharma news,

USFDA approves Myovant & Pfizer’s Myfembree for management of moderate to severe pain associated with endometriosis

According to the companies, Myfembree is also approved for heavy menstrual bleeding associated with uterine fibroids in pre-menopausal women.

August 8, 2022 13:22 IST

Pfizer India partners with Max Super Speciality Hospitals to give fellowship to young doctors

The biopharmaceutical major claims that the fellowship program will provide young clinicians and researchers at all 17 Max Speciality Hospitals…

July 15, 2022 19:32 IST

GSK, vaccines, health news, pharma news,

BioNTech, Pfizer to begin testing “universal” vaccine for all forms of coronavirus

Meanwhile, BioNTech also said that it was independently working on precision antibiotics that can kill “superbugs” that have grown resistant…

June 30, 2022 18:16 IST

Pfizer to buy 8.1 percent stake in French vaccines company Valneva

Pfizer will buy the stake in Valneva, which is also working on its COVID-19 vaccine, at a price of 9.49…

June 20, 2022 14:03 IST

The price represents a 33% premium over Biohaven's 90-day weighted average trading price of $111.70 for Biohaven Pharmaceutical Holding Co. Ltd., which is based in New Haven, Connecticut.

Pfizer to spend $11.6 billion on migraine treatment maker Biohaven

The New York drugmaker said Tuesday it will pay $148.50 in cash for each share of Biohaven, which makes Nurtec…

May 10, 2022 17:40 IST

Speaking to select journalists, S Sridhar, country manager, Pfizer India, said that the Chennai centre will primarily focus on developing small molecules, innovative formulations and APIs for global markets.

Pfizer sets up global drug development centre in Chennai, first in Asia for firm

Pfizer has invested $20 million (Rs 150 crore) for the 61,000 sq ft research and technology centre at the IIT…

May 5, 2022 01:15 IST

Pfizer/BioNTech say booster dose increases protection against Omicron in kids aged 5-11

Blood serum analysis of a few pediatric participants who received a booster dose in the study showed a 36-fold increase…

April 14, 2022 16:38 IST

FDA OKs another Pfizer, Moderna COVID booster for 50 and up

The Food and Drug Administration’s decision opens a fourth dose of the Pfizer or Moderna vaccines to those people at…

March 29, 2022 20:45 IST

European Medicines Agency, EMA, Moderna, COVID-19 vaccine, Pfizer vaccine, Europe, Russia, Turkey

European Medicines Agency authorizes Moderna shot for 6 to 11 age group children

The EU regulator’s vaccines chief Dr Marco Cavaleri said the Moderna vaccine for younger children will be a half-dose of…

March 4, 2022 12:50 IST

Pfizer vaccine less effective against COVID-19 in kids aged 5-11: Study

For hospitalisations, vaccine effectiveness fell from 85 per cent to 73 per cent over the same time frame, they said.

Updated: March 1, 2022 18:38 IST

EMA, Pfizer, COVID-19, adolescents, BioNTech, EU, Spikevax

European Medicine Agency recommends Pfizer COVID-19 booster for adolescents

The European Medicine Agency’s (EMA) Committee for Medicinal Products for Human Use recommendations will be followed by final decisions by…

Updated: February 25, 2022 14:10 IST

US regulators give full approval to Pfizer Covid-19 vaccine

The move could lift public confidence in the shots and spur more companies, universities and local governments to make vaccinations…

August 23, 2021 21:43 IST

Pfizer, Pfizer in India, Pfizer Covid vaccine, Pfizer corona vaccine, coronavirus, corona vaccine, covid vaccine news

Pfizer in final stages of agreement to supply vaccine doses to India: CEO Dr Albert Bourla

Pfizer is confident of producing three billion doses of COVID-19 vaccines and another four billion by next year, making it…

Updated: June 22, 2021 20:33 IST

Covid-19 vaccine: Govt examining Pfizer’s request for indemnity, will take decision on merit, says VK Paul

At a press conference, Paul said, “Yes we are engaged with Pfizer and they have indicated the availability of a…

May 27, 2021 22:26 IST

Related News

‘Worth every sleepless night’: 18-year-old wakes up at 3 am to run a global AI startup tackling Alzheimer’s

Meta CEO Mark Zuckerberg’s highest-paid employee Alexandr Wang tells teens how to build a lucrative tech future

Frisco police arrested 22-year-old Manojh Lella on charges including arson and threat

Who is Manojh Lella? Indian-American student arrested in Texas over arson, terror threat

Green card holders, US citizenship, naturalized citizens, naturalization process, denaturalization

Green card holders turned US citizens face new denaturalization threat under Trump

The 50% market monopoly powering the ‘steel skeleton’ of the global tyre industry. (Image Source: Canva)

Not MRF, not Apollo: The ‘skeleton’ stock inside every 2nd car in India

Fintech IPO rush seen in 2026

Market5 hr ago

Fintech startups, including Aye Finance, InCred Holdings, and PhonePe, are preparing to go public in 2026, along with other companies like Innoviti, PayNearby, and Niyo. This reflects the stable funding environment and a shift towards profitability and long-term growth. Ze and other startups are also expected to join the trend of dominating the IPO market.

View all shorts